Form 4 filed by Jiang Wenbin
Jiang Wenbin filed this Form 4 on CTKB (Cytek Biosciences, Inc.) with 12 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-20 21:03:07 UTC.
- Accession
- 0001872873-26-000007
- Filer
- CIK 1872873
- Filed
- 2026-11-20
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: CTKB · Cytek Biosciences, Inc. (CIK 1831915)
- Jiang Wenbin director, officer (PRESIDENT AND CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-18 | M exercised | +11,781 | 5,572,810 | D | |
| Common Stock | 2026-11-18 | F withheld for tax | -4,636 | $5.92 | 5,568,174 | D |
| Common Stock | 2026-11-18 | M exercised | +22,100 | 5,590,274 | D | |
| Common Stock | 2026-11-18 | F withheld for tax | -8,697 | $5.92 | 5,581,577 | D |
| Common Stock | 2026-11-18 | M exercised | +29,002 | 5,610,579 | D | |
| Common Stock | 2026-11-18 | F withheld for tax | -11,413 | $5.92 | 5,599,166 | D |
| Common Stock | 2026-11-18 | M exercised | +57,212 | 5,656,378 | D | |
| Common Stock | 2026-11-18 | F withheld for tax | -22,513 | $5.92 | 5,633,865 | D |
| Restricted Stock Units derivative | 2026-11-18 | M exercised | -11,781 | $0 | 15,713 | D |
| Restricted Stock Units derivative | 2026-11-18 | M exercised | -22,100 | $0 | 117,873 | D |
| Restricted Stock Units derivative | 2026-11-18 | M exercised | -29,002 | $0 | 270,692 | D |
| Restricted Stock Units derivative | 2026-11-18 | M exercised | -57,212 | $0 | 762,842 | D |